Topic
Clinical Trials
How Congo's Ebola Trial Uses a Typhoid Shot to Test Ervebo
The first Ebola vaccine trial in Congo's Bundibugyo outbreak offers every volunteer the candidate within about a month, which keeps the blinded comparison short. Here is what that design can and cannot show.
A 42% Cut in Melanoma Relapse Means 12 More Per 100 at Two Years
The headline 42% blends a flat first six months with a later effect. In people, the companies' two-year figures mean about 12 more per 100 recurrence-free, with survival still unknown.
Why Placebos Still Work Even When Patients Know They're Fake
Patients told plainly that their pills contain no medicine still report real relief. The effect is genuine, but it has limits worth understanding.